Skandinaviska Enskilda Banken (SEB)’s Cytokinetics CYTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-88,684	Closed	-$5.64M	–	305
2025 Q4	$5.64M	Sell	88,684 -61,273	-41%	-$3.81M	0.02%	395
2025 Q3	$8.24M	Buy	149,957 +110,568	+281%	+$4.55M	0.03%	318
2025 Q2	$1.3M	Sell	39,389 -111,519	-74%	-$3.88M	0.01%	626
2025 Q1	$6.06M	Sell	150,908 -31,218	-17%	-$1.43M	0.03%	374
2024 Q4	$8.59M	Buy	182,126 +26,332	+17%	+$1.37M	0.04%	318
2024 Q3	$8.22M	Hold	155,794	–	–	0.04%	305
2024 Q2	$8.44M	Hold	155,794	–	–	0.04%	287
2024 Q1	$10.9M	Buy	155,794 +126,348	+429%	+$9.77M	0.05%	257
2023 Q4	$2.46M	Sell	29,446 -21,695	-42%	-$786K	0.01%	536
2023 Q3	$1.51M	Hold	51,141	–	–	0.01%	605
2023 Q2	$1.67M	Buy	51,141 +5,028	+11%	+$186K	0.01%	593
2023 Q1	$1.62M	Sell	46,113 -2,238	-5%	-$91.3K	0.01%	593
2022 Q4	$2.21M	Sell	48,351 -2,801	-5%	-$121K	0.02%	515
2022 Q3	$2.48M	Sell	51,152 -7,949	-13%	-$383K	0.02%	491
2022 Q2	$2.32M	Hold	59,101	–	–	0.02%	534
2022 Q1	$2.18M	Hold	59,101	–	–	0.01%	607
2021 Q4	$2.69M	Hold	59,101	–	–	0.01%	577
2021 Q3	$2.11M	Buy	+59,101	New	+$1.74M	0.01%	633